Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Sugammadex and Neostigmine for Recovery From Rocuronium
Sponsor: Ain Shams University
Summary
evaluation the reversal of neuromuscular blocking by sugammadex versus neostigmine through assessing the residual neuromuscular blocking effect by ultrasound imaging of expiratory muscle strength and diaphragmatic excursion.
Official title: Sugammadex Versus Neostigmine for Recovery of Respiratory Muscle Strength Measured by Ultrasonography in the Postextubation Period in Laparoscopic Cholecystectomy
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-01-01
Completion Date
2024-08-01
Last Updated
2024-05-29
Healthy Volunteers
No
Conditions
Interventions
using of sugammadex and neostigmine for reversal from rocuronium and assessment of response using ultrasound and nerve stimulation
patients will be randomly divided into two groups using a computer generated random number chart. Group S will receive sugammadex for reversal of rocuronium, whereas Group N will receive neostigmine for reversal of rocuronium using nerve stimulation and ultrasound to asses recovery of respiratory muscle
Locations (1)
Faculty of Medicine, Ain Shams University
Cairo, Egypt